General Surgery Service, Hospital Italiano de Buenos Aires, Juan D. Perón 4190, C1181ACH, Buenos Aires, Argentina.
J Gastrointest Surg. 2013 Apr;17(4):814-21. doi: 10.1007/s11605-012-2092-2. Epub 2012 Nov 27.
Posthepatectomy liver failure is the most severe complication after major hepatectomies and it is associated with an insufficient future liver remnant (FLR). Associating liver partition and portal vein ligation (PVL) has recently been described as a revolutionary strategy to induce a rapid and large FLR volume increase. We aim to describe our surgical technique, patient management, and preliminary results with this new two-stage approach.
During the first stage, liver partition and PVL of the diseased hemiliver are performed. The completion surgery is carried out after volumetric studies have demonstrated a sufficient FLR and provided the patient is in good condition. This is usually achieved after 7 days. In the second step, the patient undergoes a completion surgery with right hepatectomy, right trisectionectomy, or left trisectionectomy.
Fifteen patients with advanced liver tumors were treated. Nine patients were males and the mean age was 54 years old. The mean difference between the preoperative and postoperative FLR volume was 303 ml (p < 0.001), which represented a mean volume increase of 78.4 %. All resections were R0. Morbidity and mortality rates were 53 and 0 %, respectively. The average hospital stay was 19 days.
The presented technique was feasible and safe in the hands of experienced hepatobiliary surgeons, with satisfactory short-term results. It induces rapid liver hypertrophy and at the same time it offers the possibility of cure to patients previously declared unresectable.
肝切除术后肝功能衰竭是肝切除术最严重的并发症,与肝剩余量(FLR)不足有关。联合肝脏离断和门静脉结扎(PVL)最近被描述为一种诱导快速和大量 FLR 体积增加的革命性策略。我们旨在描述我们的手术技术、患者管理和这种新的两阶段方法的初步结果。
在第一阶段,对患病半肝进行肝脏离断和 PVL。完成手术是在体积研究表明有足够的 FLR 并且患者状况良好后进行的。这通常在 7 天后实现。在第二步中,患者接受完成手术,行右半肝切除术、右三叶切除术或左三叶切除术。
15 例晚期肝肿瘤患者接受了治疗。9 例为男性,平均年龄为 54 岁。术前和术后 FLR 体积的平均差异为 303ml(p<0.001),这代表了平均 78.4%的体积增加。所有切除均为 R0。发病率和死亡率分别为 53%和 0%。平均住院时间为 19 天。
在有经验的肝胆外科医生手中,该技术是可行和安全的,具有令人满意的短期结果。它能迅速诱导肝肥大,同时为以前被认为不可切除的患者提供治愈的可能性。